Robuta

GlobalData tracks 78 drugs in development for T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia) by 63 companies/universities/institutes....

We report a novel somatic mutation in the kinase domain of JAK2 (R938Q) in a high-risk pediatric case of B-cell acute lymphoblastic leukemia (ALL). The patient...

Efforts to cure BCR::ABL1 B cell acute lymphoblastic leukemia (Ph+ ALL) solely through inhibition of ABL1 kinase activity have thus far been insufficient...

The FDA has approved inotuzumab ozogamicin, an antibody-drug conjugate, for pediatric patients with certain leukemias.

Our single-center experience real-world data in treating T-ALL/LBL-AYA patients with pediatric-inspired protocol demonstrates encouraging results of high...

ADMA is elevated in adult childhood ALL survivors, which can reflect late detrimental chemotherapy effects, partially related to minor lipid profile changes....

40 yrs old Male asked about What causes acute lymphoblastic leukemia?, 1 doctor answered this and 310 people found it useful. Get your query answered 24*7 only...

We investigated the efficacy of cord blood transplantation (CBT) for adult acute lymphoblastic leukemia (ALL) by reviewing medical records of 256 patients...

The meaning of LYMPHOBLAST is a lymphocyte that has enlarged following stimulation by an antigen, has the capacity to recognize the stimulating antigen, and is...

Childhood Acute Lymphoblastic Leukemia (ALL) is a malignant lymphoid disease of which B-cell precursor- (BCP) and T-cell- (T) ALL are subtypes. The role of...

Acute lymphoblastic leukemia (ALL), also called acute lymphocytic leukemia, is a cancer of the immature forms of white blood cells called lymphocytes.

Learn more about Acute Lymphoblastic Leukemia (ALL) and the resources we have available. ||

Jul 7, 2022 - Acute lymphoblastic leukemia (ALL) is a type of blood cancer and the most common cancer among children. Treatment can often lead to remission or a cure. Learn...

Samuel John, M.D., is an Assistant Professor of Pediatrics at UT Southwestern; he specializes in pediatric blood cancers and cell therapy.

Resistance to DT2216 is rare in a wide variety of T-ALL cells but when it occurs is correlated with decreased BCL-XL degradation. Resistance to DT2216 in T-ALL...

Oct 29, 2025 - Published: October 29, 2025Written by: Saul WisniaNolan Young has aspirations of a career in both the Air Force and FBI, and even at age 15 it’s easy to...

Blinatumomab is under clinical development by Amgen and currently in Phase III for Lymphoblastic Lymphoma.

Maintenance treatments for acute lymphoblastic leukemia (ALL) include chemotherapy, targeted therapy and CNS prophylaxis or treatment.

Acute lymphoblastic leukemia (ALL) is currently treated with an intense regimen of chemotherapy yielding cure rates near 85%. However, alterations to treatment...

The PBS subsidises blinatumomab, dasatinib, imatinib, inotuzumab ozogamicin and ponatinib for patients with acute lymphoblastic leukaemia.

The global acute lymphoblastic leukemia therapeutics market is highly lucrative, and is primarily driven by the growing incidence and prevalence of leukemia.

A new compound that locks a disease-related protein into an inactive position stifled the growth of an aggressive form of leukemia in laboratory and animal...

Participation in this study will last up to 15 years, which includes long-term follow up. Participants will be followed closely for the first month after...

Near-haploid acute lymphoblastic leukemia is rare subgroup of the disease, which is very important due to very poor prognosis and resistance to treatment...

scientific article published on 01 July 1990

Doctors for Childhood Acute Lymphoblastic Leukemia - Book Doctor Appointment, Consult Online, View Doctor Fees, User Reviews, Address and Phone Numbers of...

Doctors for Acute lymphoblastic Leukemia in Kurla, Mumbai - Book Doctor Appointment, Consult Online, View Doctor Fees, User Reviews, Address and Phone Numbers...

This study revealed that the recurrent deletion of MAP3K7/CASP8AP2 is associated with SIL-TAL1 fusions and a mature immunophenotype, but not with response to...

scientific article published on 01 April 1993

The TLX1 transcription factor oncogene is frequently activated by chromosomal translocations in T-cell acute lymphoblastic leukemia (T-ALL) and defines a...

Review hematology test results, microscopy, and how the HORIBA Yumizen H1500 aids in delta checks for chemotherapy or hematolymphoid malignancy follow-ups.

Acute Lymphoblastic Leukemia Guidelines

Doctors for Acute lymphoblastic Leukemia in Bhayandar West, Mumbai - Book Doctor Appointment, Consult Online, View Doctor Fees, User Reviews, Address and Phone...

Refractory/relapsed pediatric acute leukemia are still clinically challenging and new therapeutic strategies are needed. Interactions between Natural Killer ...

Daratumumab is under clinical development by Johnson & Johnson and currently in Phase II for Precursor B-Cell Lymphoblastic Leukemia-Lymphoma.

Thailand Acute Lymphocytic Lymphoblastic Leukemia Therapeutics Market Industry is expected to grow 11.42 USD Billion by 2032. The Thailand Acute Lymphocytic...

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) has been a cornerstone in the treatment of adult acute lymphoblastic leukemia (ALL). Its...

Doctors for Acute lymphoblastic Leukemia in IC Colony, Mumbai - Book Doctor Appointment, Consult Online, View Doctor Fees, User Reviews, Address and Phone...

Acute lymphoblastic leukemia is the most common type of cancer in children. Learn about the treatment options for childhood ALL.

B Cell Acute Lymphoblastic Leukemia